PDB17 TOTAL Cost of Care and Utilization Among Medicare Fee-for-Service (FFS) Patients with Metastatic Pancreatic Cancer Treated with FDA-Approved/NCCN® Category 1 Regimens at 340B VS. NON-340B Hospitals
| Autor: | Tomicki, S., Latimer, H., Dieguez, G., Cockrum, P., Kim, G.P. |
|---|---|
| Zdroj: | In Value in Health June 2021 24 Supplement 1:S80-S81 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect